Policy | December 20, 2023
Norms for fixing prices of medicines
NPPA fixes the ceiling price of scheduled formulations as per the extant provisions of DPCO, 201
NPPA fixes the ceiling price of scheduled formulations as per the extant provisions of DPCO, 201
The products are slated to be manufactured at the Ankleshwar facility and is expected to start contributing meaningfully to the revenue from FY25
The Regional Reference Laboratory in Chennai is equipped with cutting-edge diagnostic technologies
This development is a strategic part of the company's commitment to bolstering its position in the advanced pharmaceutical intermediates segment
Expansion of presence in India with electrical safety, electromagnetic compatibility and medical device biocompatibility, toxicity and microbiology testing and certification services
GMM Pfaudler US completes acquisition of MixPro
Jan Ausahdhi exhibited demonstration stall during 42nd India International Trade Fair to spread awareness
Collaboration enables Brenntag to serve pharma customers in EMEA with chromatography silica gels
XTANDI becomes the first and only androgen receptor signaling inhibitor approved for use with or without a GnRH analog therapy in nonmetastatic castration-sensitive prostate cancer
Reports revenue growth of 9% to INR 882 crores in Q2 FY24
Subscribe To Our Newsletter & Stay Updated
